Similarly, decreased expression of cyclin B1 and increased expression of p21 during G2/M arrest after reversine treatment were also reported in prostate cancer (Hsieh et al., 2007) and renal cancer (Cheng et al., 2018). This evidence concerns the gene CCNB1 and prostate carcinoma.